The push to develop better anti-aging products based on genetics got a shot in the arm recently. Access Business Group has signed a $1.2 million deal with Interleukin Genetics which will see the latter working on identifying genetic factors that play a role in aging.

Access Business Group is not the only company looking for another way to capitalize on the booming anti-aging skincare market. Proctor & Gamble Beauty (P&G) based on information from studies presented at the 21^st World Congress of Dermatology in October 2007, plans on furthering research in the area. P&G hopes to use genetics to help it develop skincare products that will not only ‘slow the processes that influence skin aging, but will also help the skin heal itself.’